@biorxivpreprint New preprint of our work in Dr. Peter F. Johnsonโs laboratory. Please leave your comments and help us make this a better manuscript. Thank you all for your help.
The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.
Today, FDA approved the first COVID-19 vaccine for the prevention of #COVID19 disease in individuals 16 years of age and older. https://t.co/iOqsxXV1fj